What's new

Human medicines European public assessment report (EPAR): Pylclari, piflufolastat (18F), Date of authorisation: 27/11/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Pylclari, piflufolastat (18F), Date of authorisation: 27/11/2023, Revision: 5, Status: Authorised

May 26, 2025 - 13:35
 0
Human medicines European public assessment report (EPAR): Pylclari, piflufolastat (18F), Date of authorisation: 27/11/2023, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Pylclari, piflufolastat (18F), Date of authorisation: 27/11/2023, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab,...

Next Article

Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vac...

Related Posts

Annex - National provisions for SMEs applicable to the ...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Rytelo, imetelstat, Date of authorisation: 07/03/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

National competent authorities (human)

National competent authorities (human)

May 22, 2025  0